Spain

Spain

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
0.75 (0.67 - 0.83) 2019 Modelled IHME
0.76 (0.68 - 0.83) 2018 Modelled IHME
0.76 (0.69 - 0.84) 2017 Modelled IHME
0.79 (0.70 - 0.87) 2016 Modelled IHME
0.81 (0.72 - 0.90) 2015 Modelled IHME
0.82 (0.73 - 0.91) 2014 Modelled IHME
0.83 (0.75 - 0.91) 2013 Modelled IHME
0.84 (0.75 - 0.93) 2012 Modelled IHME
0.85 (0.76 - 0.94) 2011 Modelled IHME
0.86 (0.76 - 0.95) 2010 Modelled IHME
0.87 (0.78 - 0.96) 2009 Modelled IHME
0.88 (0.79 - 0.97) 2008 Modelled IHME
0.89 (0.80 - 0.99) 2007 Modelled IHME
0.9 (0.81 - 1) 2006 Modelled IHME
0.91 (0.82 - 1.02) 2005 Modelled IHME
0.92 (0.83 - 1.03) 2004 Modelled IHME
0.93 (0.84 - 1.03) 2003 Modelled IHME
0.94 (0.84 - 1.04) 2002 Modelled IHME
0.95 (0.85 - 1.05) 2001 Modelled IHME
0.96 (0.85 - 1.07) 2000 Modelled IHME
0.97 (0.87 - 1.07) 1999 Modelled IHME
0.98 (0.88 - 1.08) 1998 Modelled IHME
0.99 (0.89 - 1.09) 1997 Modelled IHME
1 (0.89 - 1.10) 1996 Modelled IHME
1.01 (0.90 - 1.12) 1995 Modelled IHME
1.02 (0.91 - 1.12) 1994 Modelled IHME
1.02 (0.93 - 1.13) 1993 Modelled IHME
1.03 (0.93 - 1.15) 1992 Modelled IHME
1.04 (0.94 - 1.16) 1991 Modelled IHME
1.05 (0.95 - 1.18) 1990 Modelled IHME
0 (0 - 1) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.4 (0.80 - 2.20) 2002 Survey/reported Salleras L et al, 2007
0.7 (0.50 - 1) 2009 Survey/reported Pedraza-Flechas et al, 2014
0.8 (0.60 - 1.10) 2016 Modelled ECDC
0.57 (0.44 - 0.72) 2015 Modelled WHO
0.6 (0.40 - 0.90) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.04) 2019 Modelled IHME
0.03 (0.02 - 0.04) 2018 Modelled IHME
0.03 (0.02 - 0.04) 2017 Modelled IHME
0.03 (0.02 - 0.04) 2016 Modelled IHME
0.03 (0.02 - 0.04) 2015 Modelled IHME
0.03 (0.02 - 0.04) 2014 Modelled IHME
0.03 (0.02 - 0.04) 2013 Modelled IHME
0.03 (0.02 - 0.04) 2012 Modelled IHME
0.03 (0.02 - 0.04) 2011 Modelled IHME
0.03 (0.02 - 0.04) 2010 Modelled IHME
0.03 (0.02 - 0.04) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.05) 2005 Modelled IHME
0.04 (0.03 - 0.06) 2004 Modelled IHME
0.06 (0.04 - 0.07) 2003 Modelled IHME
0.07 (0.05 - 0.10) 2002 Modelled IHME
0.09 (0.06 - 0.12) 2001 Modelled IHME
0.1 (0.07 - 0.13) 2000 Modelled IHME
0.1 (0.07 - 0.13) 1999 Modelled IHME
0.1 (0.08 - 0.14) 1998 Modelled IHME
0.1 (0.08 - 0.14) 1997 Modelled IHME
0.11 (0.08 - 0.14) 1996 Modelled IHME
0.11 (0.08 - 0.14) 1995 Modelled IHME
0.13 (0.10 - 0.17) 1994 Modelled IHME
0.18 (0.13 - 0.23) 1993 Modelled IHME
0.24 (0.18 - 0.31) 1992 Modelled IHME
0.33 (0.24 - 0.41) 1991 Modelled IHME
0.41 (0.30 - 0.53) 1990 Modelled IHME
0.19 (0.12 - 0.27) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.55 2017 Survey/reported ECDC Monitoring Report
People who inject drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported ECDC
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.50) 2009 Survey/reported Salleras L et al, 2009
Prisoners
Download
Value (%) Year Type Source
2.6 (0.80 - 4.50) 2008 Survey/reported Garcia-Guerrero J et al, 2010
2.6 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
409,142 (366,537 - 456,797) 1990 Modelled IHME
406,053 (365,147 - 451,313) 1991 Modelled IHME
403,133 (362,020 - 447,512) 1992 Modelled IHME
400,370 (361,873 - 443,057) 1993 Modelled IHME
397,839 (357,366 - 440,442) 1994 Modelled IHME
395,632 (355,078 - 439,159) 1995 Modelled IHME
393,955 (351,959 - 435,265) 1996 Modelled IHME
392,911 (351,709 - 433,971) 1997 Modelled IHME
392,455 (351,476 - 433,372) 1998 Modelled IHME
392,571 (349,590 - 433,269) 1999 Modelled IHME
393,389 (348,828 - 436,272) 2000 Modelled IHME
394,931 (351,991 - 436,273) 2001 Modelled IHME
397,005 (354,631 - 437,564) 2002 Modelled IHME
399,250 (358,655 - 441,258) 2003 Modelled IHME
401,306 (359,930 - 446,186) 2004 Modelled IHME
403,151 (361,010 - 449,329) 2005 Modelled IHME
404,408 (364,262 - 448,249) 2006 Modelled IHME
405,021 (366,023 - 449,225) 2007 Modelled IHME
405,049 (365,840 - 447,692) 2008 Modelled IHME
404,040 (363,247 - 448,168) 2009 Modelled IHME
401,909 (358,739 - 447,513) 2010 Modelled IHME
399,145 (358,344 - 441,248) 2011 Modelled IHME
395,676 (355,689 - 436,583) 2012 Modelled IHME
391,165 (352,535 - 430,408) 2013 Modelled IHME
385,494 (344,148 - 426,038) 2014 Modelled IHME
378,451 (338,422 - 420,903) 2015 Modelled IHME
366,110 (327,988 - 403,164) 2016 Modelled IHME
354,697 (318,096 - 390,819) 2017 Modelled IHME
349,177 (311,975 - 382,700) 2018 Modelled IHME
345,692 (307,911 - 382,208) 2019 Modelled IHME
287,000 (208,000 - 401,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.07 (1.59 - 2.63) 2019 Modelled IHME
2.06 (1.59 - 2.62) 2018 Modelled IHME
2.05 (1.58 - 2.62) 2017 Modelled IHME
2.03 (1.56 - 2.60) 2016 Modelled IHME
2.04 (1.58 - 2.59) 2015 Modelled IHME
2.01 (1.57 - 2.55) 2014 Modelled IHME
2.03 (1.59 - 2.55) 2013 Modelled IHME
2.07 (1.64 - 2.61) 2012 Modelled IHME
2.09 (1.66 - 2.63) 2011 Modelled IHME
2.11 (1.68 - 2.64) 2010 Modelled IHME
2.15 (1.71 - 2.70) 2009 Modelled IHME
2.2 (1.75 - 2.74) 2008 Modelled IHME
2.26 (1.79 - 2.81) 2007 Modelled IHME
2.29 (1.83 - 2.87) 2006 Modelled IHME
2.36 (1.87 - 2.96) 2005 Modelled IHME
2.51 (2 - 3.14) 2004 Modelled IHME
2.8 (2.24 - 3.51) 2003 Modelled IHME
3.09 (2.47 - 3.86) 2002 Modelled IHME
3.33 (2.67 - 4.16) 2001 Modelled IHME
3.47 (2.78 - 4.34) 2000 Modelled IHME
3.57 (2.85 - 4.44) 1999 Modelled IHME
3.57 (2.85 - 4.46) 1998 Modelled IHME
3.57 (2.87 - 4.44) 1997 Modelled IHME
3.63 (2.92 - 4.49) 1996 Modelled IHME
3.63 (2.92 - 4.51) 1995 Modelled IHME
3.64 (2.92 - 4.50) 1994 Modelled IHME
3.67 (2.94 - 4.54) 1993 Modelled IHME
3.72 (2.95 - 4.60) 1992 Modelled IHME
3.79 (3.01 - 4.74) 1991 Modelled IHME
3.81 (2.99 - 4.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
954 (732 - 1,212) 2019 Modelled IHME
951 (733 - 1,210) 2018 Modelled IHME
950 (732 - 1,217) 2017 Modelled IHME
945 (728 - 1,208) 2016 Modelled IHME
953 (738 - 1,208) 2015 Modelled IHME
945 (734 - 1,198) 2014 Modelled IHME
955 (747 - 1,201) 2013 Modelled IHME
977 (772 - 1,229) 2012 Modelled IHME
988 (781 - 1,241) 2011 Modelled IHME
993 (787 - 1,242) 2010 Modelled IHME
1,005 (797 - 1,257) 2009 Modelled IHME
1,016 (805 - 1,265) 2008 Modelled IHME
1,026 (812 - 1,277) 2007 Modelled IHME
1,029 (819 - 1,285) 2006 Modelled IHME
1,043 (827 - 1,307) 2005 Modelled IHME
1,091 (867 - 1,364) 2004 Modelled IHME
1,198 (957 - 1,498) 2003 Modelled IHME
1,299 (1,036 - 1,621) 2002 Modelled IHME
1,379 (1,103 - 1,721) 2001 Modelled IHME
1,415 (1,134 - 1,771) 2000 Modelled IHME
1,439 (1,151 - 1,792) 1999 Modelled IHME
1,427 (1,142 - 1,784) 1998 Modelled IHME
1,416 (1,139 - 1,762) 1997 Modelled IHME
1,434 (1,154 - 1,775) 1996 Modelled IHME
1,428 (1,149 - 1,772) 1995 Modelled IHME
1,426 (1,145 - 1,762) 1994 Modelled IHME
1,435 (1,148 - 1,772) 1993 Modelled IHME
1,449 (1,150 - 1,790) 1992 Modelled IHME
1,474 (1,169 - 1,843) 1991 Modelled IHME
1,479 (1,161 - 1,877) 1990 Modelled IHME
1,610 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
9 (6 - 14) 2019 Modelled IHME
9 (7 - 14) 2018 Modelled IHME
10 (7 - 14) 2017 Modelled IHME
10 (7 - 14) 2016 Modelled IHME
10 (7 - 14) 2015 Modelled IHME
10 (7 - 14) 2014 Modelled IHME
10 (7 - 14) 2013 Modelled IHME
10 (7 - 14) 2012 Modelled IHME
9 (7 - 14) 2011 Modelled IHME
9 (7 - 14) 2010 Modelled IHME
10 (7 - 14) 2009 Modelled IHME
10 (7 - 14) 2008 Modelled IHME
10 (7 - 14) 2007 Modelled IHME
10 (7 - 14) 2006 Modelled IHME
10 (7 - 14) 2005 Modelled IHME
10 (7 - 14) 2004 Modelled IHME
10 (7 - 14) 2003 Modelled IHME
10 (7 - 15) 2002 Modelled IHME
10 (7 - 15) 2001 Modelled IHME
10 (7 - 15) 2000 Modelled IHME
10 (7 - 15) 1999 Modelled IHME
10 (7 - 15) 1998 Modelled IHME
10 (7 - 15) 1997 Modelled IHME
10 (7 - 15) 1996 Modelled IHME
10 (7 - 15) 1995 Modelled IHME
10 (7 - 15) 1994 Modelled IHME
11 (7 - 15) 1993 Modelled IHME
11 (7 - 15) 1992 Modelled IHME
11 (7 - 15) 1991 Modelled IHME
11 (7 - 15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
97 2004 Survey/reported WHO/UNICEF
81 2003 Survey/reported WHO/UNICEF
82 2002 Survey/reported WHO/UNICEF
83 2001 Survey/reported WHO/UNICEF
77 2000 Survey/reported WHO/UNICEF
80 1999 Survey/reported WHO/UNICEF
81 1998 Survey/reported WHO/UNICEF
84 1997 Survey/reported WHO/UNICEF
82 1996 Survey/reported WHO/UNICEF
96 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
119 2016 Survey/reported ECDC
119 2016 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.98 (0.79 - 1.18) 2019 Modelled IHME
0.97 (0.79 - 1.18) 2018 Modelled IHME
0.96 (0.79 - 1.18) 2017 Modelled IHME
0.95 (0.78 - 1.17) 2016 Modelled IHME
0.95 (0.77 - 1.17) 2015 Modelled IHME
0.95 (0.77 - 1.17) 2014 Modelled IHME
0.95 (0.78 - 1.17) 2013 Modelled IHME
0.96 (0.78 - 1.17) 2012 Modelled IHME
0.96 (0.78 - 1.18) 2011 Modelled IHME
0.97 (0.78 - 1.18) 2010 Modelled IHME
0.95 (0.77 - 1.15) 2009 Modelled IHME
0.89 (0.74 - 1.07) 2008 Modelled IHME
0.83 (0.70 - 0.99) 2007 Modelled IHME
0.78 (0.66 - 0.92) 2006 Modelled IHME
0.76 (0.65 - 0.89) 2005 Modelled IHME
0.77 (0.66 - 0.90) 2004 Modelled IHME
0.8 (0.69 - 0.93) 2003 Modelled IHME
0.84 (0.72 - 0.98) 2002 Modelled IHME
0.88 (0.75 - 1.02) 2001 Modelled IHME
0.91 (0.77 - 1.06) 2000 Modelled IHME
0.93 (0.79 - 1.09) 1999 Modelled IHME
0.96 (0.80 - 1.12) 1998 Modelled IHME
0.98 (0.82 - 1.16) 1997 Modelled IHME
0.99 (0.83 - 1.18) 1996 Modelled IHME
1 (0.83 - 1.20) 1995 Modelled IHME
1 (0.83 - 1.18) 1994 Modelled IHME
1 (0.83 - 1.18) 1993 Modelled IHME
0.99 (0.83 - 1.19) 1992 Modelled IHME
0.98 (0.82 - 1.17) 1991 Modelled IHME
0.96 (0.80 - 1.16) 1990 Modelled IHME
0.8 (0.30 - 1.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.26 (0.14 - 0.42) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
64.4 2016 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
0.4 (0 - 2.30) 2015 Survey/reported Garcia-Alonso, 2016
1.1 (0.30 - 2.80) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.7 (0.40 - 2.60) 2014 Modelled Gower et al, 2014
1.5 2019 Modelled Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2 2017 Survey/reported ECDC
4.2 2019 Modelled Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
4.9 (2.90 - 7.50) 2019 Modelled Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis
People who inject drugs (PWID)
Download
Value (%) Year Type Source
71 (69.50 - 72.50) 2012 Modelled Degenhardt L et al, 2017
64.4 2016 Survey/reported ECDC
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.2 (0.10 - 0.30) 2012 Survey/reported Seisdedos T et al, 2011
Prisoners
Download
Value (%) Year Type Source
20.3 (18.90 - 21.70) 2009 Modelled ECDC
44.9 2010 Survey/reported ECDC
42.9 2010 Survey/reported ECDC
38.9 2010 Survey/reported ECDC
37.8 2010 Survey/reported ECDC
37.2 2010 Survey/reported ECDC
33 2010 Survey/reported ECDC
3,029 2010 Survey/reported ECDC
27 2010 Survey/reported ECDC
25.3 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
373,098 (312,073 - 448,613) 1990 Modelled IHME
380,346 (317,400 - 456,471) 1991 Modelled IHME
385,472 (322,283 - 461,816) 1992 Modelled IHME
388,909 (324,559 - 461,727) 1993 Modelled IHME
391,177 (325,071 - 464,104) 1994 Modelled IHME
392,818 (327,496 - 471,711) 1995 Modelled IHME
392,264 (326,699 - 466,099) 1996 Modelled IHME
388,454 (324,733 - 459,196) 1997 Modelled IHME
382,710 (321,478 - 449,014) 1998 Modelled IHME
376,391 (319,115 - 439,283) 1999 Modelled IHME
371,025 (315,380 - 432,581) 2000 Modelled IHME
363,992 (311,497 - 421,258) 2001 Modelled IHME
353,734 (303,115 - 410,016) 2002 Modelled IHME
343,399 (293,238 - 398,822) 2003 Modelled IHME
336,411 (286,805 - 391,747) 2004 Modelled IHME
336,759 (286,536 - 393,156) 2005 Modelled IHME
351,516 (297,774 - 410,351) 2006 Modelled IHME
379,741 (317,058 - 449,310) 2007 Modelled IHME
412,790 (342,003 - 493,427) 2008 Modelled IHME
440,868 (359,544 - 534,174) 2009 Modelled IHME
454,023 (366,214 - 553,771) 2010 Modelled IHME
454,831 (368,718 - 554,713) 2011 Modelled IHME
452,903 (368,055 - 551,639) 2012 Modelled IHME
449,393 (365,910 - 548,846) 2013 Modelled IHME
445,712 (362,784 - 548,586) 2014 Modelled IHME
443,155 (360,779 - 547,620) 2015 Modelled IHME
444,417 (364,762 - 545,120) 2016 Modelled IHME
447,113 (364,529 - 546,947) 2017 Modelled IHME
448,207 (365,948 - 545,068) 2018 Modelled IHME
448,841 (362,710 - 544,260) 2019 Modelled IHME
386,000 (159,000 - 557,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
26,800 (14,000 - 43,100) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
10.5 (8.76 - 12.20) 2019 Modelled IHME
10.4 (8.63 - 12.10) 2018 Modelled IHME
10.3 (8.50 - 12.10) 2017 Modelled IHME
10.2 (8.51 - 12) 2016 Modelled IHME
10.2 (8.49 - 11.90) 2015 Modelled IHME
9.97 (8.34 - 11.70) 2014 Modelled IHME
9.89 (8.27 - 11.60) 2013 Modelled IHME
9.9 (8.28 - 11.60) 2012 Modelled IHME
9.83 (8.21 - 11.50) 2011 Modelled IHME
9.78 (8.16 - 11.50) 2010 Modelled IHME
9.87 (8.23 - 11.60) 2009 Modelled IHME
9.96 (8.30 - 11.70) 2008 Modelled IHME
10.1 (8.35 - 11.90) 2007 Modelled IHME
10.1 (8.39 - 12) 2006 Modelled IHME
10.3 (8.62 - 12.20) 2005 Modelled IHME
10.5 (8.73 - 12.40) 2004 Modelled IHME
10.6 (8.80 - 12.60) 2003 Modelled IHME
10.5 (8.73 - 12.50) 2002 Modelled IHME
10.4 (8.62 - 12.40) 2001 Modelled IHME
10.4 (8.60 - 12.40) 2000 Modelled IHME
10.5 (8.74 - 12.60) 1999 Modelled IHME
10.4 (8.66 - 12.40) 1998 Modelled IHME
10.3 (8.57 - 12.40) 1997 Modelled IHME
10.3 (8.52 - 12.40) 1996 Modelled IHME
10.2 (8.42 - 12.30) 1995 Modelled IHME
10.1 (8.35 - 12.10) 1994 Modelled IHME
10 (8.27 - 12.20) 1993 Modelled IHME
10 (8.23 - 12.20) 1992 Modelled IHME
10 (8.21 - 12.20) 1991 Modelled IHME
9.95 (8.11 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,817 (4,031 - 5,638) 2019 Modelled IHME
4,785 (3,988 - 5,614) 2018 Modelled IHME
4,762 (3,942 - 5,616) 2017 Modelled IHME
4,743 (3,961 - 5,569) 2016 Modelled IHME
4,755 (3,966 - 5,580) 2015 Modelled IHME
4,679 (3,914 - 5,476) 2014 Modelled IHME
4,653 (3,894 - 5,447) 2013 Modelled IHME
4,671 (3,905 - 5,460) 2012 Modelled IHME
4,637 (3,872 - 5,434) 2011 Modelled IHME
4,594 (3,834 - 5,385) 2010 Modelled IHME
4,601 (3,840 - 5,400) 2009 Modelled IHME
4,595 (3,827 - 5,399) 2008 Modelled IHME
4,583 (3,798 - 5,393) 2007 Modelled IHME
4,543 (3,764 - 5,370) 2006 Modelled IHME
4,565 (3,804 - 5,407) 2005 Modelled IHME
4,553 (3,790 - 5,396) 2004 Modelled IHME
4,523 (3,762 - 5,383) 2003 Modelled IHME
4,412 (3,671 - 5,253) 2002 Modelled IHME
4,303 (3,565 - 5,123) 2001 Modelled IHME
4,240 (3,509 - 5,062) 2000 Modelled IHME
4,247 (3,528 - 5,074) 1999 Modelled IHME
4,162 (3,465 - 4,977) 1998 Modelled IHME
4,089 (3,403 - 4,905) 1997 Modelled IHME
4,085 (3,366 - 4,908) 1996 Modelled IHME
4,017 (3,312 - 4,830) 1995 Modelled IHME
3,954 (3,273 - 4,759) 1994 Modelled IHME
3,920 (3,231 - 4,750) 1993 Modelled IHME
3,902 (3,208 - 4,760) 1992 Modelled IHME
3,901 (3,190 - 4,744) 1991 Modelled IHME
3,858 (3,145 - 4,726) 1990 Modelled IHME
4,316 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
55 (45 - 65) 2019 Modelled IHME
55 (45 - 65) 2018 Modelled IHME
55 (45 - 65) 2017 Modelled IHME
55 (45 - 65) 2016 Modelled IHME
55 (44 - 65) 2015 Modelled IHME
55 (44 - 65) 2014 Modelled IHME
55 (44 - 65) 2013 Modelled IHME
55 (44 - 64) 2012 Modelled IHME
55 (44 - 64) 2011 Modelled IHME
54 (44 - 64) 2010 Modelled IHME
54 (44 - 64) 2009 Modelled IHME
54 (43 - 63) 2008 Modelled IHME
53 (43 - 63) 2007 Modelled IHME
53 (42 - 62) 2006 Modelled IHME
52 (42 - 62) 2005 Modelled IHME
52 (42 - 62) 2004 Modelled IHME
52 (42 - 62) 2003 Modelled IHME
52 (41 - 62) 2002 Modelled IHME
52 (41 - 62) 2001 Modelled IHME
52 (41 - 62) 2000 Modelled IHME
52 (41 - 62) 1999 Modelled IHME
52 (41 - 62) 1998 Modelled IHME
51 (41 - 62) 1997 Modelled IHME
51 (40 - 61) 1996 Modelled IHME
51 (40 - 61) 1995 Modelled IHME
51 (40 - 61) 1994 Modelled IHME
51 (40 - 61) 1993 Modelled IHME
50 (40 - 61) 1992 Modelled IHME
50 (40 - 61) 1991 Modelled IHME
50 (41 - 61) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
119 2016 Survey/reported ECDC
119 2016 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
29,151 2017 Survey/reported ECDC, 2019
29,151 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.75 (%)
2019
(0.67 - 0.83(%))
IHME
HCV (RNA/cAg+)
0.98 (%)
2019
(0.79 - 1.18(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.7 (%)
2009
(0.5 - 1(%))
Pedraza-Flechas et al, 2014
HCV (anti-HCV)
0.4 (%)
2015
(0 - 2.3(%))
Garcia-Alonso, 2016

Hepatitis related deaths (national)

Modelled

HBV
954
2019
(732 - 1,212)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4,817
2019
(4,031 - 5,638)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.03 (%)
2019, latest modelled
(0.02 - 0.04(%))
IHME

Prevalence PWID

HCV
64.40 (%)
2016, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
119
2016
ECDC
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources